# FDA 483 - Carlos Timaran, MD - January 15, 2026

Source: https://www.keypedia.com/records/483/carlos-timaran-md/45ac1f54-c66b-4439-abf8-7e142aee4ad0

> FDA 483 for Carlos Timaran, MD on January 15, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Carlos Timaran, MD
- Inspection Date: 2026-01-15
- Product Type: other
- Office Name: Dallas District Office
- Summary: An FDA inspection of Mirza S. Baig, MD, Clinical Investigator in Dallas, TX, revealed significant deficiencies in the conduct of a clinical study. The firm failed to promptly report serious adverse events to the Institutional Review Board and maintained inaccurate and incomplete subject case history records. These issues indicate a lack of adherence to investigational plans and proper documentation practices.

## Related Officers

- [Terri E. Gibson](https://www.keypedia.com/people/terri-e-gibson/f1a80f95-a5c4-4cae-9a4b-e23f367770bb)

Company: https://www.keypedia.com/companies/carlos-timaran-md/06a7fe7b-a82e-4444-b6a7-8d41ee78d929

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9